Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Multiplex MRM assay for evaluation of cancer

Multiplex MRM assay for evaluation of cancer

US Patent 10725051 · Granted Jul 28, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Predicting optimal chemotherapy for CRC2020
OPRT expression and cancer treatment outcome2020
Quantifying MGMT protein for optimal cancer therapy of glioblastoma2020
SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) protein2020
SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) protein2020
SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) protein2020
Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed2020
SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein2020
SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein2020
SRM/MRM assay for the fibroblast growth factor receptor 2 (FGFR2) protein2020
SRM/MRM assay for the fibroblast growth factor receptor 2 (FGFR2) protein2020
SRM/MRM assay for the fibroblast growth factor receptor 2 (FGFR2) protein2020